Related Experiment Video
Updated: Aug 9, 2025

Urinary Bladder Distention Evoked Visceromotor Responses as a Model for Bladder Pain in Mice
Published on: April 27, 2014
Relationship between sexual and bladder dysfunction in women consuming ketamine
Bor-En Jong1, Shang-Jen Chang1,2, Chia-Hua Li3
1Division of Urology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei, Taiwan.
Female ketamine abusers experiencing lower urinary tract symptoms (LUTS) are more likely to have female sexual dysfunction (FSD). This highlights the importance of addressing LUTS in this population.
Area of Science:
- Urology
- Psychiatry
- Pharmacology
Background:
- Ketamine abuse is prevalent, yet research on female sexual dysfunction (FSD) in ketamine abusers (KAs) is scarce.
- This study addresses the under-investigated area of FSD in women misusing ketamine.
Purpose of the Study:
- To compare FSD and lower urinary tract symptoms (LUTS) between street and hospital-based KAs.
- To identify risk factors associated with FSD and LUTS in KAs.
Main Methods:
- A cross-sectional study involving 139 female KAs (aged ≥18) who completed anonymous questionnaires.
- Data collected on drug use history, FSD symptoms, and LUTS severity using validated scales (ICSI, ICPI, BSRS-5).
Main Results:
- FSD was reported by 76% of participants; 97% of hospital KAs vs. 68% of street KAs experienced FSD (P < 0.001).
- LUTS were significantly more prevalent in hospital KAs (71%) than street KAs (8%) (P < 0.001).
- LUTS, longer ketamine use (≥36 months), and psychological symptoms (BSRS-5 ≥6) were significant risk factors for FSD and LUTS.
Conclusions:
- Female ketamine abusers with LUTS are significantly more likely to experience FSD.
- Sexual health issues in KAs, particularly those with LUTS, warrant clinical attention.
Related Concept Videos
Nursing Assessment of the Genitourinary System I: Health History
Imaging Studies I: Kidney, Ureter, and Bladder Studies
Anatomy of the Genitourinary System II: Bladder and Urethra
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Nursing Assessment of the Genitourinary System II: Inspection and Palpation

